September 15, 2021
Magenta Therapeutics
Magenta Therapeutics Announces IND Clearance For MGTA-117 Targeted Conditioning Clinical Trial
September 15, 2021
Jounce Therapeutics
Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
September 13, 2021
Casma Therapeutics
Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
September 10, 2021
Fulcrum Therapeutics
Fulcrum Therapeutics™ Appoints Mel Hayes as Chief Commercial Officer
September 09, 2021
Decibel Therapeutics
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss